Trial intelligence / Profile preview

Disulfiram for Cocaine Dependence in DBH Genotypes

NCT00149630Phase 2Completed

Sponsor
Baylor College of Medicine
Start
Jan 2005
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in cocaine dependence comparing Disulfiram Arm with Placebo Arm (2 arms). Primary endpoint: Urine Toxicology for Cocaine. Started Jan 2005; status: completed.

02

Drugs

disulfiram
03

Conditions

cocaine dependence

Beyond the preview

Go deeper on NCT00149630.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00149630.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call